Werewolf Therapeutics HOWL
NASDAQ HOWL
$0.98 -0.03 (-2.97%)
At close: Oct 23, 2026 · 4:00 PM EDT

Werewolf Therapeutics (HOWL) Other Accumulated Expenses (2021 - 2023)

Updated

Werewolf Therapeutics (HOWL) recorded Other Accumulated Expenses of $1.61 million in Q2 2023, down 86.4% from $11.82 million a year earlier and down 61.3% from the prior quarter.

Analysis

Werewolf Therapeutics (HOWL) Other Accumulated Expenses (2021 - 2023) Analysis & Trends

At the end of FY2022, Werewolf Therapeutics reported Other Accumulated Expenses of $6.53 million.

  • The Q2 2023 figure is the lowest quarterly Other Accumulated Expenses since Q1 2021.
  • Per Business Quant, the preceding three quarters came in at $4.15 million (Q1 2023), $6.53 million (Q4 2022) and $10.5 million (Q3 2022).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn
10 Werewolf Therapeutics 47.63 Mn -143.63 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 1.61 Mn
Mar 31, 2023 4.15 Mn
Dec 31, 2022 6.53 Mn
Sep 30, 2022 10.50 Mn
Jun 30, 2022 11.82 Mn
Mar 31, 2021 20,000.00
API Access

Werewolf Therapeutics Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=HOWL&period=max&api_key=YOUR_API_KEY